Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0008 | 0.0461 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1 | 0.27 | 0.5032 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.0179 | 0.0335 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0014 | 0.0026 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0008 | 0.0461 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.1968 | 0.5358 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0021 | 0.0014 | 0.0021 |
Schistosoma mansoni | nAChR subunit (ShAR1-alpha-like) | 0.0081 | 0.0179 | 1 |
Onchocerca volvulus | 0.0081 | 0.0179 | 0.0166 | |
Brugia malayi | SWIRM domain containing protein | 0.0021 | 0.0014 | 0.0019 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0021 | 0.0014 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0021 | 0.0014 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.005 | 0.0093 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0021 | 0.0014 | 0.0021 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.005 | 0.0069 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.1968 | 0.5358 | 1 |
Schistosoma mansoni | amine oxidase | 0.0021 | 0.0014 | 0.078 |
Mycobacterium ulcerans | oxidoreductase | 0.0021 | 0.0014 | 0.0076 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0021 | 0.0014 | 0.0021 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0021 | 0.0014 | 0.0026 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0021 | 0.0014 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0295 | 0.0766 | 1 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.1 | 0.27 | 1 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0014 | 0.0019 |
Mycobacterium ulcerans | dehydrogenase | 0.0021 | 0.0014 | 0.0076 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0021 | 0.0014 | 0.0021 |
Echinococcus multilocularis | 0.0021 | 0.0014 | 0.0026 | |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.1 | 0.27 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0008 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.1968 | 0.5358 | 1 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0274 | 0.0709 | 1 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0021 | 0.0014 | 0.0021 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0008 | 0.5 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0008 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0021 | 0.0014 | 0.0011 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0021 | 0.0014 | 0.0021 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0021 | 0.0014 | 0.0026 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.005 | 0.278 |
Plasmodium vivax | hypothetical protein, conserved | 0.0021 | 0.0014 | 0.0021 |
Brugia malayi | Cation transporter family protein | 0.0081 | 0.0179 | 0.0247 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.1968 | 0.5358 | 1 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0021 | 0.0014 | 0.078 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0021 | 0.0014 | 0.0082 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0093 | 0.0128 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0093 | 0.0173 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.0179 | 0.0335 |
Leishmania major | telomerase reverse transcriptase, putative | 0.1 | 0.27 | 0.5032 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0008 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.1968 | 0.5358 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0295 | 0.0766 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.1968 | 0.5358 | 1 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0021 | 0.0014 | 0.0026 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0014 | 0.0026 |
Brugia malayi | Telomerase reverse transcriptase | 0.266 | 0.7257 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0008 | 0.0015 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0014 | 0.0026 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0805 | 0.2166 | 0.4044 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.0164 | 0.0306 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1 | 0.27 | 0.5032 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.1 | 0.27 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.1968 | 0.5358 | 1 |
Schistosoma mansoni | nAChR subunit (ShAR1-beta-like) | 0.0081 | 0.0179 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0014 | 0.0026 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0093 | 0.0173 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0021 | 0.0014 | 0.0011 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.1968 | 0.5358 | 1 |
Brugia malayi | P38 map kinase family protein 2 | 0.1968 | 0.5358 | 0.7383 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.1968 | 0.5358 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.1968 | 0.5358 | 1 |
Giardia lamblia | Telomerase catalytic subunit | 0.1 | 0.27 | 1 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0021 | 0.0014 | 0.0076 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0008 | 0.0011 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0008 | 0.0015 |
Schistosoma mansoni | amine oxidase | 0.0021 | 0.0014 | 0.078 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0021 | 0.0014 | 0.0019 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0014 | 0.0026 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.1 | 0.27 | 0.5032 |
Mycobacterium ulcerans | monoamine oxidase | 0.0021 | 0.0014 | 0.0076 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0021 | 0.0014 | 0.078 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0014 | 0.0026 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0021 | 0.0014 | 0.0026 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0093 | 0.0128 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.1968 | 0.5358 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0021 | 0.0014 | 0.0021 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0021 | 0.0014 | 0.0082 |
Onchocerca volvulus | 0.0081 | 0.0179 | 0.0166 | |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0008 | 0.5 |
Onchocerca volvulus | 0.0081 | 0.0179 | 0.0166 | |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0008 | 0.0015 |
Leishmania major | UDP-galactopyranose mutase | 0.0021 | 0.0014 | 0.0011 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 16 ug ml-1 | Tested for the minimum inhibitory concentration (MIC) against growth of PAM 1032 , a strain of Pseudomonas aeruginosa | ChEMBL. | 11858997 |
MPC8 (functional) | = 2.5 ug ml-1 | Minimum concentration of the compound required to reduce (potentiate) the MIC of levofloxacin of Pseudomonas aeruginosa by 8-folds | ChEMBL. | 11858997 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.